EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A phase transition reduces the threshold for nicotinamide mononucleotide-based activation of SARM1, an NAD(P) hydrolase, to physiologically relevant levels

Janneke Doedée Icso, Paul Ryan Thompson

Journal of Biological Chemistry · 2023

DOI: 10.1016/j.jbc.2023.105284 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023. Verfasst von Janneke Doedée Icso und 1 weiteren Autor:innen. Beteiligte Einrichtung: Program in Chemical Biology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA; Department of Biochemistry and Molecular…. Hauptthemen laut MEDLINE: NAD, Nicotinamide Mononucleotide. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIGMS NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Axonal degeneration is a hallmark feature of neurodegenerative diseases. Activation of the NAD(P)ase sterile alpha and toll-interleukin receptor motif containing protein 1 (SARM1) is critical for this process. In resting neurons, SARM1 activity is inhibited, but upon damage, SARM1 is activated and catalyzes one of three NAD(P)+ dependent reactions: (1) NAD(P)+ hydrolysis to form ADP-ribose (ADPR[P]) and nicotinamide; (2) the formation of cyclic-ADPR (cADPR[P]); or (3) a base exchange reaction with nicotinic acid (NA) and NADP+ to form NA adenine dinucleotide phosphate. Production of these metabolites triggers axonal death. Two activation mechanisms have been proposed: (1) an increase in the nicotinamide mononucleotide (NMN) concentration, which leads to the allosteric activation of SARM1, and (2) a phase transition, which stabilizes the active conformation of the enzyme. However, neither of these mechanisms have been shown to occur at the same time. Using in vitro assay systems, we show that the liquid-to-solid phase transition lowers the NMN concentration required to activate the catalytic activity of SARM1 by up to 140-fold. These results unify the proposed activation mechanisms and show for the first time that a phase transition reduces the threshold for NMN-based SARM1 activation to physiologically relevant levels. These results further our understanding of SARM1 activation and will be important for the future development of therapeutics targeting SARM1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NADNicotinamide MononucleotideArmadillo Domain ProteinsAxonsHydrolasesNeuronsHumansCell LineCytoskeletal Proteins

Stichwörter der Autor:innen

NMNSARM1axon degenerationhydrolasephase transition

Substanzen

Armadillo Domain ProteinsHydrolasesNADNicotinamide MononucleotideSARM1 protein, humanCytoskeletal Proteins

Autor:innen und Institutionen

  • Program in Chemical Biology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA; Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medial School, Worces…

Förderung

  • NINDS NIH HHS
  • NIGMS NIH HHS
  • NIAID NIH HHS
  • NIGMS
  • NIAMDD
  • NINDS
  • National Institutes of Health

Zitieren

APA

Icso, J. D., & Thompson, P. R. (2023). A phase transition reduces the threshold for nicotinamide mononucleotide-based activation of SARM1, an NAD(P) hydrolase, to physiologically relevant levels. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.105284

Vancouver

Icso JD, Thompson PR. A phase transition reduces the threshold for nicotinamide mononucleotide-based activation of SARM1, an NAD(P) hydrolase, to physiologically relevant levels. Journal of Biological Chemistry. 2023. doi:10.1016/j.jbc.2023.105284

BibTeX
@article{Icso2023,
  author = {Icso, Janneke Doedée and Thompson, Paul Ryan},
  title = {A phase transition reduces the threshold for nicotinamide mononucleotide-based activation of SARM1, an NAD(P) hydrolase, to physiologically relevant levels},
  journal = {Journal of Biological Chemistry},
  year = {2023},
  doi = {10.1016/j.jbc.2023.105284}
}
Kostenlos starten →